ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Clinical trials for ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can weight-loss drugs and hormones make endometrial cancer surgery safer for obese women?
Disease control Not yet recruitingThis study tests whether a 28- to 54-week program of weight-loss medication (semaglutide), a hormone-releasing IUD, diet, and exercise is safe and feasible before surgery in women with early endometrial cancer and a BMI of 40 or higher. Eighty participants will be randomly assign…
Matched conditions: ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Phase: PHASE4 • Sponsor: Hospital Universitari de Bellvitge • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Weight-Loss drug may slow uterine tumors before surgery
Disease control Not yet recruitingThis study tests whether tirzepatide, a drug used for diabetes and weight loss, can slow or stop the growth of early-stage endometrial cancer or its precursor (EIN) in women with obesity. Forty participants will receive either tirzepatide or no additional treatment for 4 weeks be…
Matched conditions: ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a diabetes shot help beat uterine cancer without surgery?
Disease control Not yet recruitingThis study tests whether adding a weight-loss shot (tirzepatide) to standard hormone therapy can better treat early-stage uterine cancer or pre-cancer in overweight women. About 30 participants will either get the standard progesterone IUD alone or the IUD plus tirzepatide. The g…
Matched conditions: ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Pap smear upgrade? DNA test could spot hidden uterine cancer
Diagnosis Not yet recruitingThis observational study will test a new molecular test called CISENDO, which looks at DNA methylation in cells from a routine cervical smear. The goal is to see if it can accurately detect endometrial cancer or precancerous lesions in women at medium-to-high risk. Researchers wi…
Matched conditions: ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Could your daily urine predict uterine cancer?
Knowledge-focused Not yet recruitingThis study will ask 50 people aged 35 and older with abnormal uterine bleeding to collect daily urine samples and track their bleeding at home for several months. Researchers will use a home monitor to measure hormone levels and see if certain patterns are linked to uterine cance…
Matched conditions: ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC